After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations.
This website will be accessible until September 2025, with all the information being up to date as of July 2024.
If you are a supplier, or another partner you can contact our legacy email address as aidsmap@outlook.com with any queries.
We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health or happiness. Together we have made a difference.
Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).
Science Speaks
Positive Lite
The Conversation
The Advocate
Newsweek
My PrEP Experience (blog)
IRMA
BBC World Have Your Say (audio)
Newsday
The Guardian
Nursing Clio
BETA blog
AIDSMeds
New York Times
Fierce Drug Delivery
Slate
HIVand hepatitis.com
IRMA